Research status of liver transplantation in the treatment of non-alcoholic fatty liver disease
10.3969/j.issn.1674-7445.2020.03.017
- VernacularTitle:肝移植治疗非酒精性脂肪性肝病的研究现状
- Author:
Zhou YANG
1
;
Binsheng FU
Author Information
1. Department of Hepatic Surgery, Liver Transplantation Center, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
- Publication Type:Research Article
- Keywords:
Liver transplantation;
Non-alcoholic fatty liver disease (NAFLD);
Non-alcoholic fatty liver;
Nonalcoholic steatohepatitis (NASH);
Obesity;
Metabolic syndrome;
Cirrhosis;
Hepatocellular carcinoma
- From:
Organ Transplantation
2020;11(3):419-
- CountryChina
- Language:Chinese
-
Abstract:
Liver transplantation is the most effective means to treat the related end-stage liver disease caused by non-alcoholic fatty liver disease (NAFLD). But the recurrence rate of NAFLD after liver transplantation is very high due to the affection of obesity, metabolic syndrome and other adverse factors. In recent years, liver transplantation for NAFLD related end-stage liver disease has made some progress both in China and abroad. This article reviews the research progress of NAFLD and liver transplantation for NAFLD.
